Alnylam Pharmaceuticals, Inc. (ALNY)
404.46
-10.75
(-2.59%)
USD |
NASDAQ |
Dec 10, 16:00
406.00
+1.54
(+0.38%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap: 53.43B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 146.58B |
| Glaukos Corp. | 6.244B |
| Bristol Myers Squibb Co. | 104.25B |
| BridgeBio Pharma, Inc. | 14.01B |
| Vertex Pharmaceuticals, Inc. | 112.81B |
Market Cap Related Metrics
| PE Ratio | 1681.75 |
| PS Ratio | 16.59 |
| Price to Book Value | 228.46 |
| Price to Free Cash Flow | 240.62 |
| Price | 404.46 |
| Earnings Yield | 0.06% |
| Operating PE Ratio | 201.22 |
| Normalized PE Ratio | 260.93 |